Events

Featured presenter:

• Anita M. Allemand, PharmD, Senior Vice President, Enterprise Product Innovation and Development, CVS Health

Highlights:

• General Session: Market-Driven Approaches to Managing the Rise in Drug Prices
• Presenter: Anita M. Allemand, PharmD, Senior Vice President, Enterprise Product Innovation and Development, CVS Health

In the last year, drug price increases have been in the double digits in the U.S., and the increases are larger and occurring more frequently than in previous years. This issue has dominated the national media through much of 2016, led to increased congressional scrutiny, and even pushed drug pricing into the presidential campaign. But there are market-driven approaches that can help moderate the rise in prices. In fact, now more than ever, health plans and large employers need a comprehensive approach to managing rising drug prices that both improves patient care and reduces unnecessary spending.

Featured Presenter:

• Surya Singh, M.D., Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health

Highlights:

Innovation in Pharmacy Delivery: Value-Based Purchasing for Drugs
March 30, 2017

Presenters:

• Surya Singh, M.D., Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health
• Rena Conti, Ph.D, Departments of Pediatrics Hematology/Oncology and Health Studies, The University of Chicago
• Sarah Emond, Executive Vice President and Chief Operating Officer, Institute for Clinical and Economic Review

We often hear "you get what you pay for." However, that statement seems vastly oversimplified in a multifaceted drug industry where the cost of a single medication can be dictated and influenced by a number of factors. A value-based purchasing strategy, which ties payment to the manufacturer with drug efficacy, is touted as the next big solution to the pharmacy expenditure crisis. Watch experts discuss and debate the merits of value-based purchasing and its ability to control health care costs for the long term.

Featured Presenters:

• Trip Hofer, VP, Specialty Product, President of Accordant, a CVS Health company
• Theresa Juday, Senior Specialty Professional, Specialty Pharmacy, CVS Health

Highlights:

Applying Innovative Technology to Enhance the Effectiveness of a Specialty Management Model
May 8, 2016, 12:30 - 1:30pm
Presenter: Trip Hofer, VP, Specialty Product, President of Accordant, a CVS Health company

By 2020, specialty drugs will represent 55% of all drug costs, with half falling under the medical benefit. Disparate benefit systems can contribute to limited visibility into a health care payor’s true specialty drug spend, and lead to complex and fragmented care. Using automated technology to manage across medical and pharmacy benefits can help generate incremental savings opportunities while improving patient outcomes. This session will explore how technology can help transform data into actionable interventions to manage the health of complex populations, improve clinical outcomes, and deliver lowest net cost for payors.

Proactive Pipeline Management to Help Address Growing Trend
May 9, 2017, 1:00-2:00 pm
Presenter:  Theresa Juday, Senior Specialty Professional, Specialty Pharmacy, CVS Health

With specialty drugs dominating the pipeline for expensive and complex conditions including autoimmune, oncology, cystic fibrosis and even high cholesterol, it is important to have a strong foundational knowledge of the changing market. Some treatment regimens for some of the most expensive specialty drugs cost up to $400,000, while the legal and regulatory treatment of these pricey and often life-saving medications add to management complexity.  Learn about key strategies to help mitigate unnecessary drug spend.